Apollo Endosurgery Inc (APEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,854 | 12,674 | 17,282 | 20,509 | 14,264 |
| Receivables | 732 | 1,443 | 727 | 2,059 | 1,314 |
| TOTAL | $12,883 | $14,547 | $18,423 | $24,229 | $15,995 |
| Non-Current Assets | |||||
| PPE Net | 196 | 220 | 221 | 237 | 261 |
| Intangibles | 2,286 | 2,268 | 2,237 | 2,142 | 2,074 |
| Other Non-Current Assets | 77 | 77 | 77 | 77 | 77 |
| TOTAL | $2,560 | $2,565 | $2,535 | $2,457 | $2,413 |
| Total Assets | $15,443 | $17,112 | $20,958 | $26,686 | $18,407 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,742 | 2,018 | 2,865 | 2,625 | 2,544 |
| Accrued Expenses | 908 | 1,024 | 1,232 | 542 | 687 |
| TOTAL | $2,689 | $3,140 | $4,256 | $3,386 | $3,510 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 39 | 99 | 159 | 219 | 279 |
| Other Non-Current Liabilities | 0 | 600 | 850 | 1,300 | 1,700 |
| TOTAL | $16 | $626 | $886 | $1,345 | $1,755 |
| Total Liabilities | $2,706 | $3,766 | $5,142 | $4,732 | $5,265 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 382 | 252 | 251 | 250 | 203 |
| Common Shares | 26 | 19 | 19 | 19 | 16 |
| Retained earnings | -71,476 | -68,806 | -66,033 | -59,674 | -56,505 |
| TOTAL | $12,738 | $13,347 | $15,816 | $21,954 | $13,142 |
| Total Liabilities And Equity | $15,443 | $17,112 | $20,958 | $26,686 | $18,407 |